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E\enone. rcgardless of age. status or
-.r_ryni. level has expcrienced pain 10 some
&e Parn .on rn ' l  i \  r ' l  g rea l  im fonancc  i n
dental practice. It is pain that brings the
patient to the dental oflice.
Advanccs in medical research and the
discovery of analgesic drugs have given us
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Pam cortrol is ol greal imponance in dental pnctice. Il js pain ihat brings rhe palient to rhe denial
Gi: fhr usc ofDon sreroidal anti-in|ammxtory drugs is one jmponant component in dentisrry. Bul the
--:< r.lcrion of rhere drugs cause serious problems lhe adverse reaction eftects are most frequently
dr.i k, the gastrointestinal traci. such as sirnple dyspepsia or nausea. vomiling, or gasrric bl€eding. These
.t.,!d reaclion effects result liom direct gastric irritalioD or prostaglandin i hibition. Since prostaglandins
- =+onsible lor inhibitnD of gasrric acid secretion and srimulation of the cyioprotecrive mucous in th€
:rEh. most non-(eroidal anti-inflamnatory drugs can cornterac hese efTecrs. Since 1971, the mechanisrn
- 1-!on of mn-srcyoidal anti-inilammatory drugs was knowr tkough their inhibirion of prosraglandin
h..:xhcsir. These drugs prevent the synthcsis of prosraglandins lhrough rheir inhibition efTecr on the
qcr'\) genase cnzymc (COX). The unwanted side-cfie.ts of rhese drugs are due to iheir inlibition ofCOX-
L .,rle rh.i anri-inflammatory effects are due to inhibirion ofCOX-2. Severat points need ro be considered
.t rs. rhis drug safely ard effectively in dcntidrl,. Knowing the aclion of non-sleroidal anti-inflammarory
+ 3nd recognizing lhe possibil;ly ofdrug interactions i  an importanl step tow"rd preventing problems in
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some an$ve$ to questions about th€ ongms
and persistence of pain Recent advances
have led to new depths of understanding and
control. Acute Pain can be a waming
svmptom. Persistent pain is nou thought to
be an aggressivc disease in itself. producing
changes in the brain that underlie th€
patholog) of $hat we term chronrc f 'arn -
Ihe use ol  nun-sleroldal anl l - lnr lam-
matory drugs is one important component tn
dentistry. Aspirin is the archetypal non-
steroidal anti-inflammatory drugs and was
first used clinicalt) in l899 Since then
nirmerous othcr non-steroidal anti-inflam-
matorv drugs have bcen developed lhe
adverse reacrion eflects are most frequenuy
related to the gastrointestinal tract. such as
simple dyspepsia or nausea. vomiting. or
ga\tr i (  hlccdinE. I  hesc dd\trse reacl ion
eftects resull fron direci gastrrc rlritatron or
Drostaslandin inhibition. Since proslagland'ns
are reiponsible tbr i'rhibition of gastric acid
secrction and stimulaiion of the cyto-
protective mucous in the stomach- most non_
sleroidal antj-inflammalory drugs can
counteract these efTecls. In the ljnited slates.
approximatel) 20.000 cases of adverse
re;cdon to this drug have been reported and
around 2.600 proved to be fatal cases 
'
l h i .  p a n e r  l r r l l  d i . c r r s s  t h e  m e c h a n i ' m
of action and sidc effccts of non-steroidal
anti-intlammatory drugs. as well as several
attempls to use this drug safely and effective
in dentistry.
Therapeutic Uses in Dentistry
Non-steroidal anti-inflammatory drugs
rre uselul  in lhc marrdgement of dcntal  pain
Acule pdrn Li ln. ,c(ur dur ing luolh e)\ t iacl iurr '
loorh rnd sol t  l i \ \u(;niuO and si lh inlccl ion
and inflammation. This Pain can be
modulated and rcmoved by treating lts causc
dnd lhrnugh (umbincd strategies using
analgesics to treat the pain and antibiotics to
tteal lhe infection
lher( . rre numerous non-sleroidal anl i -
inflammatory drugs and each lan be used lo
treat mild to moderate Pain with an
inflammatory component:
. Mild to moderate Pain with an
inflammatory component (e g. toothache'
periodontitis. osteoartllritis. rheumatoid
arthritis)
. The pain of cancer metastas€s. injury
(e.g. surgical procedures, bone fractures)'
Action of Non-steroidtl Anti-inflam-
matory Drugs
These drugs hare potent analgesic.
antipyrctic and anti_inflanrmatory propertres-
ln 1971. Professor Sir John Vane and
coworkers proposed that th€ mechanism of
action of the aspirinJike drugs was through
their  inhibi l ion of prostaglandin bio-
synthesis.r These drugs pr€vent the synthes$
ul nro.tdgland;ns *rough lheir  inhibi l ion
efTect on the cyclooxygenase enzyme
(COX).r Physiologic concentrations of
Drostaglandins do not cause pam. but olher
intlam-aton ,nqct1316rs ruch as bradikinin
are able to trigger a painful reaction and
prostaglandin potentiaie this reaction.-
All non-steroidal anti-inflammatory
drugs inhibit COx activity and lhis effect
urderl ie\  lheir  analge<ic act iv i t )  I lvo
separate isoforms of COX have been
identified:'
. COX-I is a constitutive erlzTme found in
a wide variety of cells thrcughout the
body; it maintains the fonnation of
Drostaslandins involved in "house_
i".pi,i" (i.". control of vascular flow
through individual organs)
.  COx-2 is s) nlhesi , / rd Je novo in
inflammalory cells such as neutrophils
and mast cells following exposure to
ba(lcr ial  cndolox;n\ andor cyokines
(e.s. TNIi. II--l). It is responsible for
geierating prostaglandins at the side of
inflammation and/or tissue damage.
COX inhibition effectively blocks the
conversion of arachidonic acid to prosta-
glandins via lhc COX Pathway of the
arachidonic acid cascade this inhibition of
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:'rilaglandin synthesis explains both the
:€rrpeutic and the adverse eflects of these
li_rnrs The therapeutic effects arc achieved
rrugh the inhibition of pathological over-
r-iuction of prostaglandins which con-
:_;!te l,i lhe inflammatorv process. Ihe
!:-,.rse etlects result from the inlibition of
:':' riological formation of prostanoids.
Tbrrmacokinet ics
\lorl non-steroidal anliinflammaton
r'3. peak in abor( l-2 hours. fhe efect of
r . .: .n ahsorpli{)n ofthese drugs approved to
r":: plrin is to reduce the rate but not the
.a::.r of rbsorption of ibuproten. the
ar.,: .\.ns. and dif'lusinal. l here ;s no eflect
n: rl'rorpli(nr of these drugs with oral
m-:-r,js They are melabolized in the liver
E 3\!rctcd by the kidney. I hel mostly bind
--:rmein (90%). so inleract ion wi lh other
!- : .  .  Jn orL rrr  ({ .q.  , , ral  dnl i -c, ,aprr lnnt ) .  and
i.. :larease lnloxlca!on.
lA.rse React ions
U3srrointeslinal effects Prostaglandin
rhibrtors.  l ikc non-steroidal ant i -
rirmmatory drugs. can inlerfere !\ith
-]!1e nomial protective mechanisms in the
<^mach and increase acid secrction.
:3uiing symptoms or even an ulceration
,-\S el'fecls. lhis includes sedation.
:z2lness. confusion, mental deprcssion.
ie.rJache. vertigo and convulsions.
Plrr.'nrs raking them should be cautioncd
rnrur dr i r ing a car.
I  \ {  c lot l iDg. lhcse drugs rcvcrsibl)
!r:rbir platelrt aggregation because the]'
r.rhir TXA2 prodlction.
R-al cffccts. This includes renal liilure.
: .<rtr ; .  and an increased incidcncc ol '
r::!rn tract infbctions. The non-stercidal
-i:rniammatory drugs ha\e litllc cllccl
.:. rrlienls \\ith normal kjdncl function:
b .re\cr.  \ \ i th disease. decreases in both
renal blood flow and glomerular filtration
Otbcr effects. Oral manifestations
report€d include ulceratile stomatitis,
gingival ulcerative. and dry mouth.
Ilypersensitivilj reaction. A wide range
of sensitivity reactions. including itching,
Steven-Johnson syndrome, anaphylactoid
reaction have been reported.
Pregnancy and nursing. The non-steroidal
anti-inflammatory drugs given late in
pregmncy can prolong gestation, delay
parturition and cause premature closure
of the ductus arteriosus The ulcriDe
prostaglandins are responsible lbr
parturition and premature closure of thc
ljrug interactions. The drug interactions
of the non-steroidal anti-inflarnmalory
drugs are summarized in the table belo\a,:
How To Reduce the Adverse Reaction
ofThese Drugs
The non-sleroidal anti-inflammatory
drugs pla) an important rolc in thc
rnanagement of dental pain. To use this drug
salcly and effecti\'ely in dentistry. the
firllorving points need to be considered:7
Irteraclion of tbe non{te!o!4!lq'!i 4!!!al!t
inhibitors' Decreases sniihypencnsive
Stomatiiis. bone mafo$ loxici(y
I)ecreases NSAIDS level.Sahcylal6 or olIer NSAIDs
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L Paracetamot as the first choice ofdrug for
simple denlal cases with no or mild
inflammation
2. Give th€ smallcst cffective dose of these
drugs
1. r ; i r"e more al lenl i r 'n to $e el ' ler l ) '
cardiovascular patients, and pati€nts wlth
sastrointestinal history'
t  ihoose non steroidal anl i  inf lammalor]
drus\ lhal  .etecl ivel)  inhihi l  (  (rX )  l r r
pre;ent gastrointestinal effects'
5.  A . , 'mhinrr ion of 2 or more non-
sLeroidat nl i - in l larr lmaloD drug\ ui l l  nol
increase their effectiveness but can
incrcase toxlcrty
6. Relognize thc possibility of drug
interaotions
SummarY
The rationale ofusing non-steroidal anti-
inflammatory drugs is to treat mild to
mod€rat€ pain wiih inllarnmation component
Because these dnrgs nowadays arc easy to
bI.  o\er the (Lrunler.  \ \e ha!e ld conl lnuorls_
5 remin.t ing rhe nal ienl  dhoul the \ ide crTer I
(]f lhese druss
Ihe non_steroidal anti-inflammatory
drup,s nla) an imp. ' r tant role in lhe
roiun"t"n, of denlal pain hul the siile
. t le. i  tan carrse cl in ical  Frohlems KnowinP
the action of non-steroidal anti'inflammatory
drugs and recognizing the possibilit] oi drug
int. ' ru. t ion";"  an importanl step tosard
pre\enting problens in dental clinics-
All the results so far published support
the hvDothesis that the un$anted side_effects
of these drugs are due to their inhibition of
COX-1. white their anti-inflammatory effects
are due to inhibition of COX-2 ]he
ialentification of s€lectile inhibitors of COX-
I and COX-2 will lead to advances rn the
therapy of inflammation. espcciall' dental
ioflammation Parn
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